[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100595528":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":8,"locations":14,"responsibleParty":31,"collaborators":7,"id":35,"slug":36,"hasResults":37,"nctId":38,"briefTitle":39,"officialTitle":39,"acronym":7,"eligibilityCriteria":40,"healthyVolunteers":37,"sex":41,"minAge":42,"maxAge":7,"enrollmentInfo":43,"targetDuration":7,"studyType":46,"phases":7,"briefSummary":47,"conditions":48,"keywords":50,"overallStatus":52,"whyStopped":7,"lastUpdateSubmitDate":53,"lastUpdatePostDateStruct":54,"startDateStruct":57,"completionDateStruct":59,"leadSponsor":61,"locationsCount":62},{"fullName":5,"class":6},"Harbin Medical University","OTHER",null,[9],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},"Haibo Jia, MD","CONTACT","15945685291_","jhb101180@163.com",[15],{"facility":16,"status":7,"city":17,"state":18,"zip":19,"country":20,"countryCode":21,"cosmosGeoPoint":22,"geoPoint":27,"contacts":28},"The Second Affiliated Hospital of Harbin Medical University","Harbin","Heilongjiang","150000","China","CN",{"type":23,"coordinates":24},"Point",[25,26],126.65,45.75,{"lat":26,"lon":25},[29],{"name":10,"role":11,"phone":30,"phoneExt":7,"email":13},"15945685291",{"type":32,"investigatorFullName":33,"investigatorTitle":34,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"PRINCIPAL_INVESTIGATOR","Yu Bo","Director, Cardiology Department, the 2nd Affiliated Hospital of Harbin Medical University","100595528","cardiovascular-risk-early-screening-and-warning-in-harbin--a-prospective-cohort-study-100595528",false,"NCT07033624","Cardiovascular Risk Early Screening and Warning in Harbin : A Prospective Cohort Study","Inclusion Criteria:\n\n* 1.Residents of Harbin city, regardless of gender.\n* 2.Meets at least two of the following conditions: diabetes, hypertension, hyperlipidemia, or obesity.\n* 3.No history of cardiovascular or cerebrovascular diseases.\n* 4.Willing to participate in the study and sign the informed consent form\n\nExclusion Criteria:\n\n* 1.History of antibiotic or probiotic treatment within the past month.\n* 2\\. Pregnant women.\n* 3\\. History of autoimmune diseases or malignant tumors; severe heart, liver, or kidney dysfunction; or a history of severe cardiovascular or cerebrovascular diseases.\n* 4\\. Any unstable condition or situation that may jeopardize patient safety or compliance.\n* 5\\. Patients unable to provide informed consent due to physical reasons or unwilling to participate.","ALL","45 Years",{"count":44,"type":45},10000,"ESTIMATED","OBSERVATIONAL","The aim of this prospective cohort study is to collect the multi-omics profile of cardiovascular disease (CVD) high-risk individuals in Harbin, and to discover novel biomarker signatures of major adverse cardiovascular events (MACE) during a minimum 2-year follow-up period.",[49],"Cardiovascular Diseases",[51],"Cardiovascular diseases, microbiome, genomics, metabolism, imaging, risk prediction","NOT_YET_RECRUITING","2025-06-13",{"date":55,"type":56},"2025-06-24","ACTUAL",{"date":58,"type":45},"2025-07-01",{"date":60,"type":45},"2047-07-01",{"name":5,"class":6},1]